Mark Isalan

Title: Mark Isalan: Innovator in Gene Therapy

Introduction

Mark Isalan is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of gene therapy through his innovative work on zinc finger peptides. With a total of 2 patents, Isalan's research focuses on the modulation of gene expression and the targeting of mutant genes.

Latest Patents

Isalan's latest patents include groundbreaking work on zinc finger peptides that possess at least four zinc finger domains. These peptides can be fused to effector domains, allowing for the modulation of gene expression. His inventions are particularly useful for targeting trinucleotide-repeat sequences in mutant genes, which may have important applications in gene therapy. The patents also disclose methods for constructing poly-zinc finger peptides with arrays of at least eight zinc finger domains, along with frameworks for selecting zinc finger peptides from libraries.

Career Highlights

Throughout his career, Mark Isalan has worked with notable organizations such as the Fundació Centre de Regulació Genòmica and the Fundació Privada Centre de Regulació Genòmica. His work in these institutions has furthered the understanding and application of gene therapy techniques.

Collaborations

Isalan has collaborated with various professionals in his field, including Mireia Garriga-Canut. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Mark Isalan is a key figure in the field of gene therapy, with innovative patents that have the potential to transform medical treatments. His work on zinc finger peptides showcases his commitment to advancing scientific knowledge and improving therapeutic options.